These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19124251)

  • 1. Towards Gram-negative antivirulence drugs: new inhibitors of HldE kinase.
    Desroy N; Moreau F; Briet S; Le Fralliec G; Floquet S; Durant L; Vongsouthi V; Gerusz V; Denis A; Escaich S
    Bioorg Med Chem; 2009 Feb; 17(3):1276-89. PubMed ID: 19124251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel HldE-K inhibitors leading to attenuated Gram negative bacterial virulence.
    Desroy N; Denis A; Oliveira C; Atamanyuk D; Briet S; Faivre F; LeFralliec G; Bonvin Y; Oxoby M; Escaich S; Floquet S; Drocourt E; Vongsouthi V; Durant L; Moreau F; Verhey TB; Lee TW; Junop MS; Gerusz V
    J Med Chem; 2013 Feb; 56(4):1418-30. PubMed ID: 23409840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro screen of bacterial lipopolysaccharide biosynthetic enzymes identifies an inhibitor of ADP-heptose biosynthesis.
    De Leon GP; Elowe NH; Koteva KP; Valvano MA; Wright GD
    Chem Biol; 2006 Apr; 13(4):437-41. PubMed ID: 16632256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the glycero-manno-heptose 7-phosphate kinase domain from the bifunctional HldE protein, which is involved in ADP-L-glycero-D-manno-heptose biosynthesis.
    McArthur F; Andersson CE; Loutet S; Mowbray SL; Valvano MA
    J Bacteriol; 2005 Aug; 187(15):5292-300. PubMed ID: 16030223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic synthesis of inhibitors of the two first enzymes of the bacterial heptose biosynthetic pathway: towards antivirulence molecules targeting lipopolysaccharide biosynthesis.
    Durka M; Tikad A; Périon R; Bosco M; Andaloussi M; Floquet S; Malacain E; Moreau F; Oxoby M; Gerusz V; Vincent SP
    Chemistry; 2011 Sep; 17(40):11305-13. PubMed ID: 21922563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vectorization efforts to increase Gram-negative intracellular drug concentration: a case study on HldE-K inhibitors.
    Atamanyuk D; Faivre F; Oxoby M; Ledoussal B; Drocourt E; Moreau F; Gerusz V
    J Med Chem; 2013 Mar; 56(5):1908-21. PubMed ID: 23445125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Li HQ; Luo Y; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the Escherichia coli heptosyltransferase WaaC: binary complexes with ADP and ADP-2-deoxy-2-fluoro heptose.
    Grizot S; Salem M; Vongsouthi V; Durand L; Moreau F; Dohi H; Vincent S; Escaich S; Ducruix A
    J Mol Biol; 2006 Oct; 363(2):383-94. PubMed ID: 16963083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antibacterial efficacy of an aceraceous plant [Shantung maple (Acer truncatum Bunge)] may be related to inhibition of bacterial beta-oxoacyl-acyl carrier protein reductase (FabG).
    Zhang F; Luo SY; Ye YB; Zhao WH; Sun XG; Wang ZQ; Li R; Sun YH; Tian WX; Zhang YX
    Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):73-8. PubMed ID: 18208374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH.
    Benkovic SJ; Baker SJ; Alley MR; Woo YH; Zhang YK; Akama T; Mao W; Baboval J; Rajagopalan PT; Wall M; Kahng LS; Tavassoli A; Shapiro L
    J Med Chem; 2005 Nov; 48(23):7468-76. PubMed ID: 16279806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of potent Gram-negative specific LpxC inhibitors.
    Mansoor UF; Vitharana D; Reddy PA; Daubaras DL; McNicholas P; Orth P; Black T; Siddiqui MA
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1155-61. PubMed ID: 21273067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.
    Moreau F; Desroy N; Genevard JM; Vongsouthi V; Gerusz V; Le Fralliec G; Oliveira C; Floquet S; Denis A; Escaich S; Wolf K; Busemann M; Aschenbrenner A
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4022-6. PubMed ID: 18571407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput catch-and-release synthesis of oxazoline hydroxamates. Structure-activity relationships in novel inhibitors of Escherichia coli LpxC: in vitro enzyme inhibition and antibacterial properties.
    Pirrung MC; Tumey LN; McClerren AL; Raetz CR
    J Am Chem Soc; 2003 Feb; 125(6):1575-86. PubMed ID: 12568618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Deng L; Sundriyal S; Rubio V; Shi ZZ; Song Y
    J Med Chem; 2009 Nov; 52(21):6539-42. PubMed ID: 19888756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
    Li ZL; Li QS; Zhang HJ; Hu Y; Zhu DD; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4413-20. PubMed ID: 21752655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitors of E. coli primase, a novel bacterial target.
    Agarwal A; Louise-May S; Thanassi JA; Podos SD; Cheng J; Thoma C; Liu C; Wiles JA; Nelson DM; Phadke AS; Bradbury BJ; Deshpande MS; Pucci MJ
    Bioorg Med Chem Lett; 2007 May; 17(10):2807-10. PubMed ID: 17350255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of biochemical and biophysical tools for triage of high-throughput screening hits - A case study with Escherichia coli phosphopantetheine adenylyltransferase.
    Miller JR; Thanabal V; Melnick MM; Lall M; Donovan C; Sarver RW; Lee DY; Ohren J; Emerson D
    Chem Biol Drug Des; 2010 May; 75(5):444-54. PubMed ID: 20486930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis.
    Hammond SM; Claesson A; Jansson AM; Larsson LG; Pring BG; Town CM; Ekström B
    Nature; 1987 Jun 25-Jul 1; 327(6124):730-2. PubMed ID: 3037377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HldE Is Important for Virulence Phenotypes in Enterotoxigenic
    Maigaard Hermansen GM; Boysen A; Krogh TJ; Nawrocki A; Jelsbak L; Møller-Jensen J
    Front Cell Infect Microbiol; 2018; 8():253. PubMed ID: 30131942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466.
    Cuny GD
    Expert Opin Ther Pat; 2009 Jun; 19(6):893-9. PubMed ID: 19473108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.